The Market Reports

Index

1 Nitazoxanide Drug Market Overview
1.1 Product Overview and Scope of Nitazoxanide Drug
1.2 Nitazoxanide Drug Segment by Type
1.2.1 Global Nitazoxanide Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Nitazoxanide Drug Segment by Application
1.3.1 Global Nitazoxanide Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Global Nitazoxanide Drug Market Size Estimates and Forecasts
1.4.1 Global Nitazoxanide Drug Revenue 2016-2027
1.4.2 Global Nitazoxanide Drug Sales 2016-2027
1.4.3 Nitazoxanide Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nitazoxanide Drug Market Competition by Manufacturers
2.1 Global Nitazoxanide Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nitazoxanide Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nitazoxanide Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nitazoxanide Drug Manufacturing Sites, Area Served, Product Type
2.5 Nitazoxanide Drug Market Competitive Situation and Trends
2.5.1 Nitazoxanide Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nitazoxanide Drug Players Market Share by Revenue
2.5.3 Global Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nitazoxanide Drug Retrospective Market Scenario by Region
3.1 Global Nitazoxanide Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Nitazoxanide Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Nitazoxanide Drug Market Facts & Figures by Country
3.3.1 North America Nitazoxanide Drug Sales by Country
3.3.2 North America Nitazoxanide Drug Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Nitazoxanide Drug Market Facts & Figures by Country
3.4.1 Europe Nitazoxanide Drug Sales by Country
3.4.2 Europe Nitazoxanide Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nitazoxanide Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Nitazoxanide Drug Sales by Region
3.5.2 Asia Pacific Nitazoxanide Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Nitazoxanide Drug Market Facts & Figures by Country
3.6.1 Latin America Nitazoxanide Drug Sales by Country
3.6.2 Latin America Nitazoxanide Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Nitazoxanide Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Nitazoxanide Drug Sales by Country
3.7.2 Middle East and Africa Nitazoxanide Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Nitazoxanide Drug Historic Market Analysis by Type
4.1 Global Nitazoxanide Drug Sales Market Share by Type (2016-2021)
4.2 Global Nitazoxanide Drug Revenue Market Share by Type (2016-2021)
4.3 Global Nitazoxanide Drug Price by Type (2016-2021)

5 Global Nitazoxanide Drug Historic Market Analysis by Application
5.1 Global Nitazoxanide Drug Sales Market Share by Application (2016-2021)
5.2 Global Nitazoxanide Drug Revenue Market Share by Application (2016-2021)
5.3 Global Nitazoxanide Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Romark Laboratories
6.1.1 Romark Laboratories Corporation Information
6.1.2 Romark Laboratories Description and Business Overview
6.1.3 Romark Laboratories Nitazoxanide Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Romark Laboratories Nitazoxanide Drug Product Portfolio
6.1.5 Romark Laboratories Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Corporation Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Nitazoxanide Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Chugai Pharmaceutical Nitazoxanide Drug Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Corporation Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Nitazoxanide Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Lupin Nitazoxanide Drug Product Portfolio
6.3.5 Lupin Recent Developments/Updates

7 Nitazoxanide Drug Manufacturing Cost Analysis
7.1 Nitazoxanide Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nitazoxanide Drug
7.4 Nitazoxanide Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nitazoxanide Drug Distributors List
8.3 Nitazoxanide Drug Customers

9 Nitazoxanide Drug Market Dynamics
9.1 Nitazoxanide Drug Industry Trends
9.2 Nitazoxanide Drug Growth Drivers
9.3 Nitazoxanide Drug Market Challenges
9.4 Nitazoxanide Drug Market Restraints

10 Global Market Forecast
10.1 Nitazoxanide Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nitazoxanide Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nitazoxanide Drug by Type (2022-2027)
10.2 Nitazoxanide Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nitazoxanide Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nitazoxanide Drug by Application (2022-2027)
10.3 Nitazoxanide Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nitazoxanide Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nitazoxanide Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Nitazoxanide Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nitazoxanide Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Nitazoxanide Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nitazoxanide Drug Covered in This Study
Table 5. Global Nitazoxanide Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Nitazoxanide Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Nitazoxanide Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nitazoxanide Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nitazoxanide Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nitazoxanide Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Nitazoxanide Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nitazoxanide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nitazoxanide Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nitazoxanide Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Nitazoxanide Drug Sales Market Share by Region (2016-2021)
Table 17. Global Nitazoxanide Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Nitazoxanide Drug Sales Market Share by Country (2016-2021)
Table 20. North America Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nitazoxanide Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Nitazoxanide Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nitazoxanide Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nitazoxanide Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Nitazoxanide Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nitazoxanide Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nitazoxanide Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Nitazoxanide Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nitazoxanide Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Nitazoxanide Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nitazoxanide Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Nitazoxanide Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Nitazoxanide Drug Sales Market Share by Type (2016-2021)
Table 40. Global Nitazoxanide Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nitazoxanide Drug Revenue Share by Type (2016-2021)
Table 42. Global Nitazoxanide Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Nitazoxanide Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Nitazoxanide Drug Sales Market Share by Application (2016-2021)
Table 45. Global Nitazoxanide Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nitazoxanide Drug Revenue Share by Application (2016-2021)
Table 47. Global Nitazoxanide Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Romark Laboratories Corporation Information
Table 49. Romark Laboratories Description and Business Overview
Table 50. Romark Laboratories Nitazoxanide Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Romark Laboratories Nitazoxanide Drug Product
Table 52. Romark Laboratories Recent Developments/Updates
Table 53. Chugai Pharmaceutical Corporation Information
Table 54. Chugai Pharmaceutical Description and Business Overview
Table 55. Chugai Pharmaceutical Nitazoxanide Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Chugai Pharmaceutical Nitazoxanide Drug Product
Table 57. Chugai Pharmaceutical Recent Developments/Updates
Table 58. Lupin Corporation Information
Table 59. Lupin Description and Business Overview
Table 60. Lupin Nitazoxanide Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Lupin Nitazoxanide Drug Product
Table 62. Lupin Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Nitazoxanide Drug Distributors List
Table 66. Nitazoxanide Drug Customers List
Table 67. Nitazoxanide Drug Market Trends
Table 68. Nitazoxanide Drug Growth Drivers
Table 69. Nitazoxanide Drug Market Challenges
Table 70. Nitazoxanide Drug Market Restraints
Table 71. Global Nitazoxanide Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 72. Global Nitazoxanide Drug Sales Market Share Forecast by Type (2022-2027)
Table 73. Global Nitazoxanide Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global Nitazoxanide Drug Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global Nitazoxanide Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 76. Global Nitazoxanide Drug Sales Market Share Forecast by Application (2022-2027)
Table 77. Global Nitazoxanide Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global Nitazoxanide Drug Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global Nitazoxanide Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 80. Global Nitazoxanide Drug Sales Market Share Forecast by Region (2022-2027)
Table 81. Global Nitazoxanide Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global Nitazoxanide Drug Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nitazoxanide Drug
Figure 2. Global Nitazoxanide Drug Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Oral Suspension Product Picture
Figure 5. Global Nitazoxanide Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Retail Pharmacy
Figure 8. Other
Figure 9. Global Nitazoxanide Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Nitazoxanide Drug Market Size 2016-2027 (US$ Million)
Figure 11. Global Nitazoxanide Drug Sales 2016-2027 (K Units)
Figure 12. Global Nitazoxanide Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Nitazoxanide Drug Sales Share by Manufacturers in 2020
Figure 14. Global Nitazoxanide Drug Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Nitazoxanide Drug Players: Market Share by Revenue in 2020
Figure 16. Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Nitazoxanide Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Nitazoxanide Drug Sales Market Share by Region in 2020
Figure 19. Global Nitazoxanide Drug Revenue Market Share by Region (2016-2021)
Figure 20. Global Nitazoxanide Drug Revenue Market Share by Region in 2020
Figure 21. United States Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Colombia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Nitazoxanide Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Nitazoxanide Drug by Type (2016-2021)
Figure 45. Sales Market Share of Nitazoxanide Drug by Application (2016-2021)
Figure 46. Sales Market Share of Nitazoxanide Drug by Application in 2020
Figure 47. Revenue Share of Nitazoxanide Drug by Application (2016-2021)
Figure 48. Revenue Share of Nitazoxanide Drug by Application in 2020
Figure 49. Manufacturing Cost Structure of Nitazoxanide Drug
Figure 50. Manufacturing Process Analysis of Nitazoxanide Drug
Figure 51. Nitazoxanide Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed